Your comprehensive poster abstract proposal(s) MUST be submitted by Friday, September 4, 2026 at 11:59 PM ET to be considered for acceptance at this year's event. Abstracts are subject to acceptance by the Scientific Review Committee. Accepted abstracts will be published in the American Journal of Gastroenterology and accepted for poster display at the 2026 AIBD conference. Only abstracts received by the submission deadline will be considered. Acceptance notifications will be sent on or before October 16, 2026.
Abstracts will be accepted in the following categories: CLINICAL, SURGERY, PEDIATRIC, NURSING/APP, or YOUNG INVESTIGATOR. Please indicate which category is appropriate by checking the appropriate box in the online submission system.
*Please note: We will no longer be accepting basic science abstracts.
Abstract Categories
CLINICAL ABSTRACT CATEGORIES
SURGERY CLINICAL ABSTRACT CATEGORIES
PEDIATRIC CLINICAL ABSTRACT CATEGORIES
NURSING/APP CLINICAL ABSTRACT CATEGORIES
YOUNG INVESTIGATOR CLINICAL ABSTRACT CATEGORIES
Abstract Guidelines
Accepted Format:
Previous Presentation, Publication and Duplication of Abstracts
Poster Abstract Awards
Abstracts are reviewed and accepted by the AIBD Scientific Review Committee. Each year the AIBD Scientific Review Committee recognizes the “Best Of” submitted abstracts. Winning abstracts receive free conference registration and a $500 scholarship to help off-set associated travel expenses. Abstract awards are given for the following categories: Clinical, Surgery, Pediatric, Nursing/APP, and Young Investigator.
Commitment
Submission of an abstract constitutes a commitment by the author(s) to 1) submit an appropriately formatted abstract poster to showcase in the AIBD poster hall, and 2) conduct an oral presentation if selected as the winning abstract for the category (i.e., Best of Surgery Abstract). Failure to present, if not justified, will jeopardize acceptance of future abstract submissions. Only the primary author or co-author may present the accepted abstract at the 2026 Advances in IBD Conference.
The conference will withdraw abstracts upon written notification from the submitting author by October 24, 2026. Acceptance of the abstract obligates the author to present the paper.
Printed Poster Guidelines
All accepted posters are expected to be present on-site at Advances in IBD 2026, which will be held at the Walt Disney World Dolphin Hotel from December 7-9, 2026. Poster abstracts will be made available to attendees via the conference app, but no virtual versions of posters will be presented.
Size Recommendations:
FAQs
Q: Where do I submit a virtual version of my poster?
A: Due to being a fully live conference, we will not utilize virtual versions of posters. Simply bring your physical poster with you on site to Orlando. Accepted abstracts will be available for attendees to view in our Conference App, but you do not need to provide anything to us prior to being on site.
Q: If I cannot attend the live meeting in Orlando, will my abstract still be published in ACG and the Conference App?
A: Yes, by being accepted, your abstract will automatically be published in ACG’s journal supplement as well as be available to attendees via our Conference App.
Q: I cannot attend the conference, but a fellow author wants to attend and present in my place. Is this possible?
A: Per to our guidelines, co-authors may present the poster on site at AIBD. However, no one from industry (even if a co-author) is allowed to present research on site at AIBD.
Q: I have more information I’d like to provide with attendees that won’t fit on my poster. Can I provide handouts?
A: Rather than providing handouts on site, we recommend adding a QR code to your poster that links to the additional information.
Q: Am I able to print my poster on site?
A: AIBD does not offer printing services onsite for posters. We strongly recommend finding a printing center that can print your poster for you prior to arriving onsite.
Q: Is there a template I need to use to design my poster?
A: There is no required template for posters. As long as your poster fits within the provided sizing guidelines, feel free to design your posters however you would like!
Q: How will I know when I need to present my poster?
A: Posters will be hung while the Exhibit Hall is open. Specific set up and tear down times will be provided to accepted poster presenters via email. We recommend standing by your poster during the Opening Reception and during Exhibit Hall breaks, but formal presentation times are not required.
Q: Do I need to register for the conference after being accepted?
A: Yes, you must register in order to present a poster at AIBD. Please refer to our rates page for more information.
Q: Are there any embargoes or restrictions on publishing the abstracts before or during the AIBD Annual meeting?
A: Yes, the complete abstract data is under embargo until after the conference on December 9, 2026.
Do you have a question that is not answered above? Please contact Kathleen Krause at kkrause@hmpglobal.com.
Congratulations to the 2025 Poster Award Winners!
Best of AIBD 2025 Pediatric Clinical Abstract
Frequency and Predictors of Change in Diagnosis to Crohn’s Disease among Children Initially Diagnosed with Ulcerative Colitis
Wei-Wei Lee, MD
Best of AIBD 2025 Young Investigator Clinical Abstract
Infliximab Discontinuation and Neighborhood Social Determinants of Health
Y. Dana Neugut, MD, MS
and
Prior Abdominal Surgery is Not Associated with Adverse Pregnancy, Delivery or Neonatal Outcomes in Women with Crohn’s Disease: Results from the PIANO Study
Erica Zurbuch, BA
Best of AIBD 2025 Surgery Clinical Abstract
Excision of Skin Tags in Perianal Crohn’s Disease: a Systematic Review
Ece Unal, MD
Best of AIBD 2025 Nurses/Advanced Practice Providers Clinical Abstract
Reducing No-Show Rates in Inflammatory Bowel Disease Clinics Using Patient Education and Appointment Confirmation
Mailenys Ortega, DNP, FNP-BC
Best of AIBD 2025 Clinical Research
Higher BMI Does Not Impair Visualization of Bowel Segments or Anastomoses in Point-of-Care Intestinal Ultrasound
Brooke Maracle, MSc
Best of AIBD 2025 Case Reports
The Overlooked Malignancy: Anal Cancer In Inflammatory Bowel Disease
Katherine Westbrook Cates, DO